top of page
team-subhead.jpg

Team

Our Mission of Discovery

At Halia Therapeutics we are discovering and developing novel therapies to improve the lives of patients with inflammatory disorders and neurological diseases. We do this by advancing innovative medicines that target the immune system's response to resolve chronic inflammation and eliminate the damage caused by aberrantly activated immune responses.

Team

david-bearss.png

David J. Bearss, PhD

President and Chief Executive Officer

jeff-burton.png

Jeff Burton, CPA/MAcc

Chief Financial Officer

Paul Flynn, V.P. Development Operations.png

Paul Flynn

V.P. Development Operations

BenBearss_Lab6.jpg

Ben Bearss

Lab Technician

jared-bearss.png

Jared Bearss, MBA

Chief Operating Officer

Alexis Mollard, Senior Director Medicinal Chemistry.png

Alexis Mollard, PhD

Sr. Director Medicinal Chemistry

Devan Bursey, Scientist.png

Devan Bursey

Scientist

Screenshot 2023-03-09 at 9.13.40 AM.png

Andrea "Andi" Groen

Director of Operations

MaggieAmsbury_Lab7.jpg

Margit Janat-Amsbury, MD, PhD

Chief Medical Officer

AnyaNeidig_Lab3.jpg

Anya Neidig, MSN, RN

Director of Clinical Operations

Taylor Avei, Lab Technician.png

Taylor Avei

Business Development Representative

HaliaGroup5.jpg

Partners

SG-logo-color.jpg
EU-logo-color.jpg
AS-logo-color.jpg
bottom of page